The cannabis sector's urge to merge shows no sign of abating. Canada's Canopy Growth Corp., headed by Bruce Linton (pictured), has agreed to buy Acreage Holdings, one of the biggest US marijuana growers, in a $3.4bn deal, notes Kimberly Chin in The Wall Street Journal.
But the tie-up comes with a twist: it depends on cannabis production and sales being legalised by the US federal government. Canopy will pay $300m upfront in cash, with the rest in shares once legalisation occurs. If it doesn't arrive within the next 90 months the deal will automatically be called off. This "non-takeover takeover" is a "smart workaround" for Canopy's shareholders, since it's risking just 2% of its $15bn market capitalisation, says John Foley on Breakingviews.
However, even though Acreage's shareholders receive a 42% premium, the deal "makes less sense" for them because they are "giving up the chance to negotiate a greater premium on a higher share price later". After all, "were cannabis to become federally legal, an established producer might have its pick of suitors".
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It also means that "Acreage shareholders are effectively taking a bet on Canopy's growth". One hint of what could be in store for the sector when legalisation does take place comes from shares in hemp firms, says Connor Smith in Barron's. Late last year Congress legalised hemp, "opening the floodgates for companies to sell "creams and sprays... said to have a calming effect". With major drugstores such as Walgreens already "on board the hemp hype train", shares in related firms have shot up.
-
December 2023 NS&I Premium Bond winners - check now to see what you’ve wonIf you hold money in NS&I Premium Bonds, you can check from today (2 December) to see if you have won in the December prize draw. Here’s how to check.
-
OpenAI – corporate drama unleashed
OpenAI, the firm behind ChatGPT, was in uproar as its boss was booted out, briefly snapped up by Microsoft and then brought back again.
-
How you can profit from the fast-growing cannabis industry
Tips Once an investment taboo, the cannabis sector is poised to thrive in 2021. David Stevenson looks at how best to buy in.
-
Profit from the long-term potential in cannabis
Tips Nawan Butt, portfolio manager of the Medical Cannabis and Wellness UCITS ETF, picks some of his favourite cannabis stocks.
-
There is still plenty of potential for investors in cannabis
Tips The cannabis sector is out of favour, but a new ETF is an appealing recovery play
-
Investors are experiencing a cannabis comedown
Features Things seemed to be turning out well for pot-heads in 2019 – and for the companies that seek to provide for their needs. Then a new, more depressing reality dawned.
-
Cash in on cannabis as a new industry emerges
Cover Story The prohibitionist era is over: countries are rapidly legalising marijuana for medical and recreational use. Ben Judge reviews the latest developments and explains how to profit from pot.
-
How to profit as marijuana becomes mainstream
Cover Story Next year recreational cannabis use becomes legal in California. With Canada also set to lift its ban, Big Weed will soon present a host of investment opportunities, says Ben Judge.
